Drug:
Reaction: ASTHMA
20260101 - 20261231
No. 301 - 400
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 301 | 26894224 |
CA |
41 | 1 |
Pneumonia, Influenza, Sinonasal obstruction, Sinusitis, Asthma, |
||||
DUPILUMAB, DUPILUMAB, ALBUTEROL SULFATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 302 | 26894978 |
US |
57 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 303 | 26895034 |
CA |
90 | |
Chronic obstructive pulmonary disease, Agitation, Confusional state, Respiratory disorder, Asthma, |
||||
OMALIZUMAB, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, ALBUTEROL SULFATE, ALBUTEROL, PREDNISONE, ALBUTEROL SULFATE, |
||||
| 304 | 26895340 |
US |
78 | 2 |
Chronic kidney disease, Major depression, Monoclonal gammopathy, Blood iron decreased, Tooth disorder, Asthma, Oesophagitis, Post herpetic neuralgia, Knee operation, Oral surgery, Hypertension, Herpes zoster, Gastrooesophageal reflux disease, Fatigue, Sleep disorder, Insomnia, Back pain, |
||||
LENALIDOMIDE, |
||||
| 305 | 26895795 |
US |
28 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 306 | 26895816 |
US |
30 | 2 |
Asthma, Drug ineffective, Product storage error, Product complaint, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 307 | 26895827 |
SA |
56 | 2 |
Hepatitis, Asthma, Lichen planus, Product dose omission issue, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 308 | 26895931 |
CA |
65 | 2 |
Wheezing, Asthma, Drug hypersensitivity, Dyspnoea, Oedema, Pneumonia, Vomiting, |
||||
AMLODIPINE BESYLATE, CIPROFLOXACIN HYDROCHLORIDE, ERGOCALCIFEROL, MONTELUKAST SODIUM, MONTELUKAST, MOXIFLOXACIN HYDROCHLORIDE, RISEDRONATE SODIUM, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, RITUXIMAB, PREDNISONE, ROPIVACAINE HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BECLOMETHASONE DIPROPIONATE, CLONAZEPAM, ROSUVASTATIN, FOLIC ACID, OMALIZUMAB, TRAMADOL HYDROCHLORIDE, |
||||
| 309 | 26896309 |
CA |
9 | 1 |
Anaphylactic reaction, Nausea, Headache, Chest pain, Haemoptysis, Urticaria, Asthma, Epistaxis, Dry skin, Cough, Eczema, Abdominal pain, Viral infection, Paraesthesia, Rhinorrhoea, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, LORAZEPAM, LORAZEPAM, ALBUTEROL SULFATE, ALBUTEROL, CICLESONIDE, |
||||
| 310 | 26896371 |
CA |
34 | 2 |
Angina unstable, Hypertension, Gait inability, Hyperhidrosis, Hypersensitivity, Pharyngeal swelling, Swollen tongue, Asthenia, Myocardial infarction, General physical health deterioration, Pain, Malaise, Feeling abnormal, Swelling face, Lymphadenopathy, Dysstasia, Pyrexia, Insomnia, Chest pain, Dizziness, Tremor, Abdominal discomfort, Weight decreased, Circadian rhythm sleep disorder, Rhinitis allergic, Influenza, Menstruation irregular, Immune system disorder, Obstructive airways disorder, Heart rate increased, Pneumonitis, Haemorrhoids, Respiratory disorder, Diarrhoea, Dysmenorrhoea, Cough, Joint swelling, Nasopharyngitis, Rash, Somnolence, Urticaria, Asthma, Dyspnoea, Speech disorder, Cardiac failure, Swelling, Product dose omission issue, Incorrect dose administered, Hypertension, Inappropriate schedule of product administration, |
||||
AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, IPRATROPIUM BROMIDE, |
||||
| 311 | 26896567 |
US |
2 | |
Asthma, |
||||
DUPILUMAB, |
||||
| 312 | 26896701 |
US |
59 | 2 |
Dyspnoea, Product physical issue, Cold sweat, Gait disturbance, Tongue disorder, Asthma, |
||||
| 313 | 26896900 |
US |
48 | 2 |
Asthma, Chest discomfort, Choking sensation, Intentional underdose, |
||||
ACECLIDINE, CIMETIDINE, PREDNISONE, |
||||
| 314 | 26897072 |
US |
56 | 1 |
Dyspnoea, Asthma, Product dose omission in error, |
||||
DUPILUMAB, DUPILUMAB, MEPOLIZUMAB, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ABATACEPT, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 315 | 26897506 |
CA |
65 | 2 |
Asthma, Oedema, Pneumonia, Wheezing, Drug hypersensitivity, Dyspnoea, Vomiting, |
||||
ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, ROPIVACAINE HYDROCHLORIDE, AMLODIPINE BESYLATE, CALCIUM GLUCONATE, CIPROFLOXACIN HYDROCHLORIDE, CLONAZEPAM, ERGOCALCIFEROL, ERGOCALCIFEROL, ERGOCALCIFEROL, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, OMALIZUMAB, OMALIZUMAB, PREDNISONE, RISEDRONATE SODIUM, RITUXIMAB, MONTELUKAST SODIUM, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, |
||||
| 316 | 26886631 |
US |
5 | 1 |
Eczema, Pruritus, Scratch, Skin hyperpigmentation, Asthma, Cough, Skin burning sensation, |
||||
DUPILUMAB, |
||||
| 317 | 26886723 |
NZ |
||
Asthma, Therapeutic product effect decreased, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 318 | 26886943 |
CA |
72 | 1 |
Antineutrophil cytoplasmic antibody positive, Anxiety, Arteriosclerosis, Arteriosclerosis coronary artery, Asthma, Condition aggravated, Conjunctivitis allergic, Dust allergy, Dyspnoea, Eosinophilic granulomatosis with polyangiitis, Forced expiratory volume decreased, Full blood count abnormal, Haemoptysis, Hypothyroidism, Hypoxia, Lung disorder, Mite allergy, Mycotic allergy, Neuritis, Neurological symptom, Nodule, Normochromic normocytic anaemia, Obstructive airways disorder, Pain in extremity, Productive cough, Pulmonary alveolar haemorrhage, Pulmonary embolism, Pulmonary fibrosis, Pulmonary vasculitis, Respiratory symptom, Skin exfoliation, Sleep disorder due to a general medical condition, Spirometry abnormal, Thrombosis, Total lung capacity abnormal, Vasculitis, Wheezing, Therapeutic product effect incomplete, Product use in unapproved indication, |
||||
FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, DUTASTERIDE, DUTASTERIDE, DUTASTERIDE, DUTASTERIDE, MEPOLIZUMAB, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, AMOXICILLIN AND CLAVULANATE POTASSIUM, APIXABAN, BUDESONIDE, BUDESONIDE, BUDESONIDE, CALCIUM CARBONATE, ANTACID, CICLESONIDE, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DOXAZOSIN, DOXAZOSIN MESYLATE, DOXAZOSIN MESYLATE, DOXAZOSIN MESYLATE, DOXAZOSIN MESYLATE, DOXAZOSIN MESYLATE, DOXAZOSIN MESYLATE, DOXAZOSIN MESYLATE, DOXAZOSIN MESYLATE, DOXAZOSIN MESYLATE, ERGOCALCIFEROL, ERGOCALCIFEROL, ESCITALOPRAM OXALATE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITALOPRAM, MAGNESIUM OXIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, MOMETASONE, CICLESONIDE, CICLESONIDE, PREDNISONE, PREDNISONE, PREDNISONE, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, APIXABAN, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, ERGOCALCIFEROL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, |
||||
| 319 | 26887078 |
US |
2 | |
Asthma, |
||||
DUPILUMAB, |
||||
| 320 | 26887082 |
US |
79 | 2 |
Injection site pain, Rib fracture, Pain, Asthma, Therapeutic response decreased, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 321 | 26887218 |
US |
56 | |
Sneezing, Loss of personal independence in daily activities, Feeling abnormal, Nightmare, Heart rate decreased, Asthma, Drug intolerance, Fatigue, Dysarthria, Vomiting, Blood pressure increased, Oxygen saturation decreased, Anxiety, Heart rate increased, Flushing, Hypotension, Dizziness, Headache, Dyspnoea, Nausea, Cough, Blood pressure decreased, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, NINTEDANIB, OXYGEN, 0XYGEN, ALBUTEROL SULFATE, ALBUTEROL, DICLOFENAC SODIUM, CYCLOBENZAPRINE, GABAPENTIN, PIRFENIDONE, CETIRIZINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CALCIUM, LIDOCAINE PATCH 5%, HYDROXYZINE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, ERGOCALCIFEROL, IRON, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FAMOTIDINE, HYDROCHLOROTHIAZIDE, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, |
||||
| 322 | 26887432 |
US |
2 | |
Fatigue, Stress, Pulmonary function test increased, Asthma, Product dose omission issue, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 323 | 26887612 |
CA |
65 | 2 |
Pneumonia, Bronchitis, Asthma, Drug ineffective, |
||||
MOMETASONE FUROATE, ALBUTEROL SULFATE, MONTELUKAST, |
||||
| 324 | 26887618 |
PR |
78 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 325 | 26887621 |
US |
64 | 2 |
Asthma, Bronchitis, |
||||
DUPILUMAB, |
||||
| 326 | 26887635 |
US |
17 | 1 |
Asthma, |
||||
DUPILUMAB, |
||||
| 327 | 26887664 |
US |
55 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 328 | 26887686 |
CA |
32 | 2 |
Abdominal pain, Anxiety, Asthma, Bacterial infection, Blood pressure increased, Cough, Decreased activity, Diarrhoea, Dizziness, Dyspnoea, Dyspnoea exertional, Ear infection, Eczema, Emphysema, Eosinophil count abnormal, Feeding disorder, Forced expiratory volume decreased, Full blood count abnormal, Fungal infection, Heart rate increased, Infection, Influenza, Loss of personal independence in daily activities, Malaise, Migraine, Middle insomnia, Musculoskeletal chest pain, Nasal congestion, Nasal discharge discolouration, Nasopharyngitis, Pneumonia, Obstructive airways disorder, Oropharyngeal pain, Pain, Productive cough, Psoriasis, Rales, Restrictive pulmonary disease, Rhinitis, Sinusitis, Sleep disorder, Sleep disorder due to a general medical condition, Stress, Tachycardia, Terminal insomnia, Tooth abscess, Upper-airway cough syndrome, Urinary tract infection, Urticaria, Vertigo, Vomiting, Wheezing, Drug ineffective, Therapeutic product effect decreased, Therapeutic response decreased, Product administration error, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, IPRATROPIUM BROMIDE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, MEPOLIZUMAB, OMALIZUMAB, |
||||
| 329 | 26888552 |
US |
18 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 330 | 26888977 |
US |
2 | |
Candida infection, Rotator cuff syndrome, Asthma, Upper limb fracture, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 331 | 26889514 |
US |
2 | |
Chest discomfort, Asthma, Product use issue, Device use error, Inappropriate schedule of product administration, Device malfunction, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 332 | 26889690 |
US |
2 | |
Asthma, |
||||
DUPILUMAB, |
||||
| 333 | 26889888 |
US |
1 | |
Hereditary disorder, Diabetes mellitus, Asthma, |
||||
EVOLOCUMAB, |
||||
| 334 | 26889942 |
CA |
51 | 2 |
Acne, Urticaria, Urticaria, Urticaria, Respiratory disorder, Pyrexia, Productive cough, Product administered at inappropriate site, Pneumonia, Peripheral swelling, Off label use, Musculoskeletal pain, Inflammation, Inappropriate schedule of product administration, Hypercholesterolaemia, Cough, Brain fog, Arthralgia, Amnesia, Gait disturbance, Drug effect less than expected, Erythema, Erythema, Fatigue, Feeling hot, Gallbladder disorder, Hair disorder, Headache, Hot flush, Influenza, Musculoskeletal stiffness, Amenorrhoea, Myalgia, Nasal congestion, Nasal discharge discolouration, Pain, Paraesthesia, Pruritus, Pruritus, Pruritus, Pruritus, Pruritus, Asthma, Pruritus, Skin plaque, Skin plaque, Skin plaque, Skin plaque, Skin sensitisation, Stress, Urticaria, Urticaria, Vaginal haemorrhage, Behaviour disorder, Weight increased, Bronchitis, Chills, Chills, Choking, Dyspnoea, |
||||
CYCLOSPORINE, CYCLOSPORINE, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ALBUTEROL SULFATE, |
||||
| 335 | 26890321 |
CA |
2 | |
Asthma, Drug hypersensitivity, Dyspnoea, Oedema, Pneumonia, Vomiting, Wheezing, |
||||
HYDROMORPHONE HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMLODIPINE, CALCIUM, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CLONAZEPAM, ERGOCALCIFEROL, FOLIC ACID, MONTELUKAST, OCRELIZUMAB, PREDNISONE, RISEDRONATE SODIUM, ROSUVASTATIN CALCIUM, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, OMALIZUMAB, MOXIFLOXACIN, MOXIFLOXACIN HYDROCHLORIDE, |
||||
| 336 | 26890332 |
CA |
43 | 2 |
Asthma, Blepharospasm, Blood cholesterol increased, Chest pain, Contusion, Decreased appetite, Deep vein thrombosis postoperative, Depression, Diarrhoea, Dizziness, Dry mouth, Exposure during pregnancy, Folliculitis, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Headache, Hepatic enzyme increased, Hypertension, Hypocholesterolaemia, Impaired healing, Infusion related reaction, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lung disorder, Memory impairment, Muscle spasms, Night sweats, Osteoarthritis, Paraesthesia, Retinitis, Rheumatoid arthritis, Stomatitis, Urticaria, Visual impairment, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, TRAMADOL HYDROCHLORIDE, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, SULFASALAZINE, BUPRENORPHINE HYDROCHLORIDE, CANDESARTAN, CANDESARTAN, CANDESARTAN, CANDESARTAN, SECUKINUMAB, SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, ERGOCALCIFEROL, FLUTICASONE PROPIONATE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, LEFLUNOMIDE, LEFLUNOMIDE, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METHYLPREDNISOLONE, MINOCYCLINE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, MEPOLIZUMAB, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PHENYLEPHRINE HYDROCHLORIDE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PYRIDOXINE HYDROCHLORIDE, RAMIPRIL, RAMIPRIL, RANITIDINE HYDROCHLORIDE, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, SULFASALAZINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, TOFACITINIB, TOFACITINIB CITRATE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, VITAMIN C, VITAMIN C, ERGOCALCIFEROL, TOFACITINIB, TOFACITINIB, |
||||
| 337 | 26890821 |
US |
2 | |
Asthma, Chest discomfort, Drug ineffective, |
||||
BENRALIZUMAB, BENRALIZUMAB, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 338 | 26891416 |
CA |
2 | |
Asthma, Drug hypersensitivity, Dyspnoea, Oedema, Pneumonia, Vomiting, Wheezing, |
||||
HYDROMORPHONE HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMLODIPINE, CALCIUM, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CLONAZEPAM, ERGOCALCIFEROL, MONTELUKAST SODIUM, MONTELUKAST, MOXIFLOXACIN HYDROCHLORIDE, OMALIZUMAB, PREDNISONE, RITUXIMAB, ROPIVACAINE HYDROCHLORIDE, ROSUVASTATIN CALCIUM, RISEDRONATE SODIUM, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, FOLIC ACID, |
||||
| 339 | 26891524 |
US |
37 | 2 |
Myocardial infarction, Supraventricular tachycardia, Asthma, Injection site pain, Contusion, Skin fissures, Pruritus, Dry skin, Skin exfoliation, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 340 | 26891542 |
CA |
65 | 2 |
Wheezing, Asthma, Pneumonia, Oedema, Drug hypersensitivity, Vomiting, Dyspnoea, |
||||
RITUXIMAB, OMALIZUMAB, CLONAZEPAM, |
||||
| 341 | 26891620 |
US |
57 | 2 |
Lower respiratory tract infection, Dysphonia, Dysphagia, Asthma, Dizziness, |
||||
TIRZEPATIDE, |
||||
| 342 | 26894308 |
73 | 1 | |
Joint swelling, Peripheral swelling, Asthma, Muscle spasms, Fatigue, Therapy cessation, |
||||
BENRALIZUMAB, PREDNISONE, ALBUTEROL SULFATE, TADALAFIL, ADALIMUMAB, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, ESOMEPRAZOLE MAGNESIUM, ERGOCALCIFEROL, |
||||
| 343 | 26881340 |
CA |
65 | 2 |
Pneumonia, Vomiting, Drug hypersensitivity, Malaise, Cough, Dyspnoea, Asthma, Chest pain, Wheezing, Respiratory tract infection, Oedema, Nasal oedema, Pain, |
||||
CALCIUM CARBONATE, FLUTICASONE PROPIONATE, CALCIUM GLUCONATE, FOLIC ACID, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, MONTELUKAST SODIUM, MONTELUKAST, MOXIFLOXACIN HYDROCHLORIDE, OMALIZUMAB, OMALIZUMAB, RISEDRONATE SODIUM, RITUXIMAB, ROPIVACAINE HYDROCHLORIDE, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, SALMETEROL XINAFOATE, MONTELUKAST SODIUM, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, AMINOPHYLLINE, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE, CLONAZEPAM, ERGOCALCIFEROL, ERGOCALCIFEROL, ERGOCALCIFEROL, AZITHROMYCIN MONOHYDRATE, CEFADROXIL, CEFADROXIL, CEFADROXIL, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, ALBUTEROL SULFATE, |
||||
| 344 | 26881388 |
US |
2 | |
Disability, Asthma, Neoplasm malignant, Ill-defined disorder, Product use in unapproved indication, |
||||
ORAL SEMAGLUTIDE, |
||||
| 345 | 26881646 |
US |
13 | 2 |
Asthma, Anxiety, Pruritus, |
||||
DUPILUMAB, |
||||
| 346 | 26881668 |
US |
44 | 2 |
Asthma, |
||||
DUPILUMAB, TEZEPELUMAB-EKKO, |
||||
| 347 | 26881694 |
US |
52 | 2 |
Anaphylactic reaction, Off label use, Asthma, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
| 348 | 26881832 |
CN |
62 | 1 |
Product packaging quantity issue, Device malfunction, Incorrect dose administered by device, Asthma, Drug resistance, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 349 | 26882103 |
0 | 2 | |
Asthma, |
||||
VIGABATRIN, |
||||
| 350 | 26882132 |
US |
2 | |
Asthma, Haemoptysis, Pneumonia aspiration, Cough, Wheezing, Dyspnoea, Chest discomfort, Sleep disorder, Loss of personal independence in daily activities, Exercise tolerance decreased, Condition aggravated, Drug ineffective, |
||||
BENRALIZUMAB, BENRALIZUMAB, DUPILUMAB, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, METRONIDAZOLE, PREDNISONE, |
||||
| 351 | 26882165 |
US |
2 | |
Asthma, |
||||
DUPILUMAB, |
||||
| 352 | 26882220 |
US |
2 | |
Asthma, |
||||
DUPILUMAB, |
||||
| 353 | 26882341 |
US |
46 | 1 |
Psoriatic arthropathy, Congenital neuropathy, Mitral valve incompetence, Neuropathy peripheral, Migraine, Gout, Essential hypertension, Gastrooesophageal reflux disease, Obstructive sleep apnoea syndrome, Rhinitis allergic, Obesity, Generalised anxiety disorder, Inguinal hernia, Asthma, Lumbosacral radiculopathy, Cervicogenic headache, Muscle spasms, Neck pain, Muscular weakness, |
||||
ERENUMAB-AOOE, ALBUTEROL SULFATE AND BUDESONIDE, AMLODIPINE BESYLATE, ATOMOXETINE HYDROCHLORIDE, ESCITALOPRAM, FEBUXOSTAT, FEBUXOSTAT TABLETS 40 MG, FEBUXOSTAT TABLETS 80 MG, GABAPENTIN, GOLIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, MAGNESIUM, METHOTREXATE, METHOTREXATE SODIUM, MONTELUKAST SODIUM, NEBIVOLOL HYDROCHLORIDE, |
||||
| 354 | 26882893 |
CA |
48 | 2 |
Peripheral venous disease, Pemphigus, Systemic lupus erythematosus, Rheumatic fever, Wound, Rheumatoid arthritis, Stomatitis, Sleep disorder, Weight increased, Abdominal discomfort, Synovitis, Seronegative arthritis, Rash, Type 2 diabetes mellitus, Road traffic accident, Swelling, Swollen joint count increased, Sleep disorder due to general medical condition, insomnia type, Visual impairment, Pulmonary fibrosis, Peripheral swelling, Joint dislocation, Bone erosion, Decreased appetite, Discomfort, Oedema peripheral, Deep vein thrombosis postoperative, Spondylitis, Headache, Drug hypersensitivity, Diarrhoea, Duodenal ulcer perforation, Lower respiratory tract infection, Ear infection, Dyspnoea, Wheezing, Muscular weakness, Abdominal pain upper, Infusion related reaction, Exostosis, Wound infection, Prescribed underdose, Sinusitis, Hepatic cirrhosis, Fatigue, Weight decreased, Fibromyalgia, Mobility decreased, Infection, Adjustment disorder with depressed mood, Depression, Sciatica, Asthenia, Liver disorder, Walking aid user, Irritable bowel syndrome, Hypercholesterolaemia, Injury, Lower limb fracture, Pneumonia, Ear pain, Tachycardia, X-ray abnormal, Retinitis, Nasopharyngitis, Respiratory disorder, Pyrexia, Muscle injury, Oedema, Urticaria, Muscle spasms, Musculoskeletal stiffness, Hip arthroplasty, Obesity, Paraesthesia, Osteoarthritis, Joint stiffness, Gait disturbance, Joint range of motion decreased, Therapeutic response decreased, C-reactive protein abnormal, Lip dry, Anti-cyclic citrullinated peptide antibody, Hand deformity, Spinal fusion surgery, Pain in extremity, Breast cancer stage II, Insomnia, Laryngitis, Glossodynia, Contusion, Autoimmune disorder, Pruritus, Chest pain, Rheumatoid factor positive, Upper respiratory tract infection, Grip strength decreased, Blood cholesterol increased, Blister, Musculoskeletal pain, Arthralgia, Gastrointestinal disorder, Red blood cell sedimentation rate increased, Pain, Vomiting, Dislocation of vertebra, Hypertension, Inflammation, Psoriatic arthropathy, Facet joint syndrome, Asthma, Pericarditis, Delirium, Lupus-like syndrome, General physical health deterioration, Osteoporosis, Abdominal pain, Arthropathy, Bursitis, Knee arthroplasty, Hypoaesthesia, Impaired healing, Lupus vulgaris, Ill-defined disorder, Anti-cyclic citrullinated peptide antibody positive, Dry mouth, Foot deformity, |
||||
SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, ERGOCALCIFEROL, APREMILAST, MORPHINE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, METHYLPREDNISOLONE SODIUM SUCCINATE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ETANERCEPT, ETANERCEPT, ETANERCEPT, SECUKINUMAB, SECUKINUMAB, PREDNISONE, PREDNISONE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, AZATHIOPRINE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, PANTOPRAZOLE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, BETAMETHASONE VALERATE, BETAMETHASONE VALERATE FOAM, BETAMETHASONE VALERATE, BETAMETHASONE VALERATE FOAM, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, VITAMIN C, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, NEOMYCIN OINTMENT, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, |
||||
| 355 | 26883826 |
US |
73 | 2 |
Spinal fusion surgery, Stress fracture, Pseudarthrosis, Upper limb fracture, Wrist fracture, Polyarthritis, Multiple fractures, Musculoskeletal stiffness, Pain in extremity, Spinal osteoarthritis, Arthralgia, Dehydration, Asthma, Vitamin D deficiency, Back pain, Fatigue, Vitamin B complex deficiency, Back pain, |
||||
DENOSUMAB, DENOSUMAB, DENOSUMAB, ROMOSOZUMAB-AQQG, ALBUTEROL SULFATE, BENAZEPRIL HYDROCHLORIDE, BETAMETHASONE DIPROPIONATE, BUDESONIDE, CETIRIZINE HCL, CETIRIZINE, CLOTRIMAZOLE, DRS. CLOTRIMAZOLE, FAMILY WELLNESS CLOTRIMAZOLE, CLOTRIMAZOLE TOPICAL, DUTASTERIDE, ESCITALOPRAM OXALATE, ESCITALOPRAM, PRASTERONE, IPRATROPIUM BROMIDE, MONTELUKAST SODIUM, MONTELUKAST, RISANKIZUMAB-RZAA, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, ERGOCALCIFEROL, |
||||
| 356 | 26884242 |
US |
45 | 1 |
Urticaria, Asthma, |
||||
DUPILUMAB, |
||||
| 357 | 26884244 |
US |
2 | |
Asthma, Hypersensitivity, Neck injury, Pain, |
||||
DUPILUMAB, |
||||
| 358 | 26884989 |
US |
56 | 2 |
Dyspnoea, Oxygen saturation decreased, Asthma, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 359 | 26885276 |
US |
2 | |
Asthma, Off label use, |
||||
OMALIZUMAB, SILDENAFIL CITRATE, SILDENAFIL, |
||||
| 360 | 26885783 |
CA |
65 | 2 |
Asthma, Chest pain, Cough, Drug hypersensitivity, Dyspnoea, Malaise, Nasal oedema, Oedema, Pain, Pneumonia, Respiratory tract infection, Vomiting, Wheezing, |
||||
FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMINOPHYLLINE, AMLODIPINE BESYLATE, BECLOMETHASONE DIPROPIONATE, CALCIUM, CALCIUM CARBONATE, ANTACID, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, ERGOCALCIFEROL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, FOLIC ACID, HYDROMORPHONE HYDROCHLORIDE, MONTELUKAST SODIUM, MONTELUKAST, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, OMALIZUMAB, OMALIZUMAB, PREDNISONE, RISEDRONATE SODIUM, RISEDRONATE SODIUM, RITUXIMAB, ROPIVACAINE HYDROCHLORIDE, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, TRAMADOL HYDROCHLORIDE, CEFADROXIL, CEFADROXIL, POLYMYXIN B SULFATE, NEOMYCIN SULFATE, |
||||
| 361 | 26885999 |
US |
59 | 2 |
Asthma, Muscle spasms, Influenza, Eye irritation, Dry skin, Eye disorder, Abdominal pain, Constipation, Dyspepsia, |
||||
TIRZEPATIDE, DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, ALBUTEROL SULFATE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DIHYDRATE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, LISINOPRIL, LORAZEPAM, PREDNISONE, ROSUVASTATIN, SERTRALINE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ALBUTEROL SULFATE, |
||||
| 362 | 26876263 |
US |
2 | |
Asthma, Inappropriate schedule of product administration, Sinus disorder, Cough, |
||||
DUPILUMAB, |
||||
| 363 | 26876275 |
GB |
76 | 1 |
Pneumonia, Asthma, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 364 | 26876661 |
US |
1 | |
Asthma, |
||||
DUPILUMAB, ALBUTEROL SULFATE, ISOTRETINOIN, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 365 | 26876893 |
US |
57 | 2 |
Asthma, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 366 | 26876971 |
CA |
46 | |
Asthma, Condition aggravated, Constipation, Oropharyngeal pain, Headache, Intentional dose omission, |
||||
OMALIZUMAB, BUDESONIDE, MONTELUKAST, |
||||
| 367 | 26877134 |
US |
14 | 2 |
Asthma, |
||||
DUPILUMAB, ALBUTEROL SULFATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 368 | 26877150 |
US |
2 | |
Asthma, Wheezing, Dyspnoea, |
||||
DUPILUMAB, |
||||
| 369 | 26877176 |
US |
52 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 370 | 26877343 |
US |
3 | 2 |
Sepsis, Acute kidney injury, Asthma, Embedded device, Pseudodementia, Blood glucose decreased, |
||||
ESKETAMINE HYDROCHLORIDE, ESKETAMINE HYDROCHLORIDE, ESKETAMINE HYDROCHLORIDE, ESKETAMINE HYDROCHLORIDE, ESKETAMINE HYDROCHLORIDE, CLONAZEPAM, ZOLPIDEM TARTRATE, |
||||
| 371 | 26878165 |
US |
66 | 1 |
Asthma, |
||||
DUPILUMAB, TIRZEPATIDE, |
||||
| 372 | 26878197 |
US |
51 | 2 |
Asthma, Drug ineffective, |
||||
DUPILUMAB, FLUCONAZOLE, LANSOPRAZOLE, METHYLPREDNISOLONE, PHENTERMINE HYDROCHLORIDE, TIOTROPIUM BROMIDE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, FLUCONAZOLE, |
||||
| 373 | 26878221 |
CA |
77 | 1 |
Death, Dyspnoea, Pneumonia, Respiratory tract infection, Sleep disorder due to a general medical condition, Headache, Asthma, Decreased activity, Ill-defined disorder, Inappropriate schedule of product administration, Drug effect less than expected, |
||||
MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, ALBUTEROL SULFATE, UMECLIDINIUM, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, |
||||
| 374 | 26878573 |
CN |
51 | 2 |
Chronic graft versus host disease in lung, Asthma, Cough, Productive cough, Sleep disorder due to general medical condition, insomnia type, Condition aggravated, |
||||
BELUMOSUDIL, |
||||
| 375 | 26879258 |
US |
72 | 2 |
Dyspnoea, Asthma, |
||||
CYCLOSPORINE OPHTHALMIC SOLUTION, |
||||
| 376 | 26879274 |
CA |
65 | 1 |
Pulmonary fibrosis, Antineutrophil cytoplasmic antibody positive, Nodule, Haemoptysis, Neuritis, Arteriosclerosis, Eosinophilic granulomatosis with polyangiitis, Mite allergy, Wheezing, Arteriosclerosis coronary artery, Vasculitis, Neurological symptom, Hypoxia, Sleep disorder due to a general medical condition, Dyspnoea, Asthma, Loss of personal independence in daily activities, Productive cough, Conjunctivitis allergic, Anxiety, Respiratory symptom, Hypothyroidism, Forced expiratory volume decreased, Lung disorder, Dust allergy, Total lung capacity abnormal, Normochromic normocytic anaemia, Full blood count abnormal, Therapeutic product effect incomplete, Pulmonary vasculitis, Pulmonary embolism, Condition aggravated, Mycotic allergy, Obstructive airways disorder, Sleep disorder, Capillaritis, Thrombosis, Pain in extremity, Spirometry abnormal, Pulmonary alveolar haemorrhage, |
||||
FLUTICASONE PROPIONATE, CALCIUM CARBONATE, ACETAZOLAMIDE SODIUM, ACETAZOLAMIDE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, AZATHIOPRINE, AZITHROMYCIN DIHYDRATE, BETAMETHASONE DIPROPIONATE, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, BUDESONIDE, CANDESARTAN, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, DOXAZOSIN MESYLATE, DUTASTERIDE, ERGOCALCIFEROL, ERGOCALCIFEROL, ESCITALOPRAM OXALATE, ESCITALOPRAM, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LIRAGLUTIDE, MAGNESIUM OXIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, MONTELUKAST SODIUM, MONTELUKAST, MOXIFLOXACIN HYDROCHLORIDE, MEPOLIZUMAB, CICLESONIDE, PANTOPRAZOLE, PENICILLIN G SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, SERTRALINE HYDROCHLORIDE, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE, SULFADIAZINE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, TAMSULOSIN HYDROCHLORIDE, VITAMIN C, ERGOCALCIFEROL, ALBUTEROL SULFATE, ALBUTEROL, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, AMOXICILLIN AND CLAVULANATE POTASSIUM, CARBAMAZEPINE, CEFUROXIME, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME SODIUM, CEPHALEXIN, CICLESONIDE, CLOTRIMAZOLE, DRS. CLOTRIMAZOLE, FAMILY WELLNESS CLOTRIMAZOLE, CLOTRIMAZOLE TOPICAL, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FUROSEMIDE, GLUCAGON, HYDROCHLOROTHIAZIDE, AZATHIOPRINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, FUROSEMIDE, THIAMINE HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, TRIMETHOPRIM, SENNOSIDES, |
||||
| 377 | 26879705 |
US |
36 | 2 |
Gallbladder disorder, Oral herpes, Asthma, Extra dose administered, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 378 | 26879781 |
US |
2 | |
Lung neoplasm malignant, Asthma, Chronic obstructive pulmonary disease, Incorrect dose administered, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 379 | 26879862 |
80 | 2 | |
Mental impairment, Tremor, Asthma, |
||||
LORATADINE, LORATADINE ORAL, LORATADINE, LORATADINE ORAL, |
||||
| 380 | 26884778 |
62 | 2 | |
Asthma, |
||||
DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, LEVOTHYROXINE SODIUM, CETIRIZINE HYDROCHLORIDE, |
||||
| 381 | 26875158 |
US |
42 | 1 |
Asthma, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 382 | 26875247 |
US |
2 | |
Illness, Asthma, |
||||
DUPILUMAB, |
||||
| 383 | 26875282 |
US |
2 | |
Asthma, |
||||
DUPILUMAB, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, BUDESONIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE (XL), FENOFIBRATE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 384 | 26875336 |
US |
9 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 385 | 26875362 |
US |
2 | |
Asthma, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 386 | 26875421 |
US |
54 | 1 |
Asthma, Dyspnoea, Sleep disorder due to a general medical condition, |
||||
DUPILUMAB, |
||||
| 387 | 26875645 |
US |
2 | |
Asthma, Sinusitis, |
||||
DUPILUMAB, LISINOPRIL, |
||||
| 388 | 26875679 |
US |
45 | 2 |
Asthma, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 389 | 26875895 |
US |
49 | 2 |
Bronchitis, Asthma, Pain, |
||||
DUPILUMAB, ENSIFENTRINE, |
||||
| 390 | 26875989 |
CA |
65 | 2 |
Pneumonia, Malaise, Pain, Drug hypersensitivity, Oedema, Cough, Vomiting, Asthma, Wheezing, Nasal oedema, Chest pain, Respiratory tract infection, Dyspnoea, |
||||
FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, CALCIUM CARBONATE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE, ROSUVASTATIN, ROSUVASTATIN, FOLIC ACID, HYDROMORPHONE HYDROCHLORIDE, MONTELUKAST SODIUM, MONTELUKAST, MONTELUKAST SODIUM, MONTELUKAST, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, OMALIZUMAB, OMALIZUMAB, PREDNISONE, RISEDRONATE SODIUM, RITUXIMAB, ROPIVACAINE HYDROCHLORIDE, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, AMINOPHYLLINE, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, BECLOMETHASONE DIPROPIONATE, ROSUVASTATIN, MOXIFLOXACIN HYDROCHLORIDE, RISEDRONATE SODIUM, ERGOCALCIFEROL, CIPROFLOXACIN HYDROCHLORIDE, CEFADROXIL, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, CEFADROXIL, |
||||
| 391 | 26872863 |
US |
2 | |
Asthma, Tracheal necrosis, |
||||
COLISTIMETHATE SODIUM, COLISTIMETHATE, |
||||
| 392 | 26873340 |
US |
62 | 2 |
Asthma, Dermatitis atopic, Aphonia, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 393 | 26873397 |
US |
1 | |
Asthma, |
||||
DUPILUMAB, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, FENOFIBRATE, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, |
||||
| 394 | 26873401 |
US |
2 | |
Cough, Asthma, Nasopharyngitis, Sinusitis, |
||||
DUPILUMAB, LEVOCETIRIZINE DIHYDROCHLORIDE, |
||||
| 395 | 26873403 |
US |
2 | |
Rhinorrhoea, Asthma, |
||||
DUPILUMAB, |
||||
| 396 | 26873498 |
BR |
70 | |
Asthma, Rhinorrhoea, Cough, Micturition urgency, Nausea, Off label use, Vomiting, Pain, Pain in extremity, Abdominal pain, Hypoaesthesia, Sinusitis, |
||||
ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, LOSARTAN, PANTOPRAZOLE, |
||||
| 397 | 26873657 |
US |
50 | 1 |
Asthma, |
||||
DUPILUMAB, |
||||
| 398 | 26873658 |
US |
10 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 399 | 26873863 |
US |
2 | |
Asthma, |
||||
DUPILUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, HYDROCHLOROTHIAZIDE, LISINOPRIL, LORATADINE, LORATADINE ORAL, MONTELUKAST SODIUM, MONTELUKAST, |
||||
| 400 | 26873967 |
US |
2 | |
Asthma, |
||||
DUPILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30